Ruderman, 1984, Prog Cardiovasc Dis, 26, 373, 10.1016/0033-0620(84)90011-2
Stamler, 1986, JAMA, 256, 2823, 10.1001/jama.1986.03380200061022
Kannel, 1971, Ann Intern Med, 74, 1, 10.7326/0003-4819-74-1-1
Endo, 1976, J Antibiot, 29, 1346, 10.7164/antibiotics.29.1346
Mabuchi, 1981, N Engl J Med, 305, 478, 10.1056/NEJM198108273050902
Bilheimer, 1983, Proc Natl Acad Sci USA, 80, 4124, 10.1073/pnas.80.13.4124
Illingworth, 1984, J Clin Invest, 74, 1972, 10.1172/JCI111618
Grundy, 1985, J Lipid Res, 26, 1464, 10.1016/S0022-2275(20)34252-8
Hoeg, 1986, Am J Cardiol, 57, 933, 10.1016/0002-9149(86)90733-2
Kovanen, 1981, Proc Natl Acad Sci USA, 78, 1194, 10.1073/pnas.78.2.1194
National Diabetes Data Group, 1979, Diabetes, 28, 1039, 10.2337/diab.28.12.1039
The National Institutes of Health Consensus Development Panel, 1984, Arteriosclerosis, 4, 296, 10.1161/01.ATV.4.3.296
American Diabetes Association, 1979, Diabetes, 28, 1027, 10.2337/diab.28.11.1027
Manual of laboratory operations: Lipid Research Clinics Program. Vol. 1. Washington, D.C: Department of Health, Education, and Welfare, 1974. (DHEW publication no. (NIH) 75–628.)
Roeschlau, 1974, Z Klin Chem Klin Biochem, 12, 226
Wahlefeld AW. Triglycerides determination after enzymatic hydrolysis. In: Bergmeyer HU, ed. Methods of enzymatic analysis. 2nd ed. Vol. 4. New York: Academic Press, 1974:1831–5.
Vega, 1984, J Lipid Res, 25, 580, 10.1016/S0022-2275(20)37771-3
Zar JH. Biostatistical analysis. 2nd ed. Englewood Cliffs, N.J.: Prentice Hall, 1984:222–5.
Winer BJ. Statistical principles in experimental design. 2nd ed. New York: McGraw-Hill, 1971:261–308.
Kannel, 1979, JAMA, 241, 2035, 10.1001/jama.1979.03290450033020
Howard, 1987, J Lipid Res, 28, 613, 10.1016/S0022-2275(20)38659-4
Taskinen, 1982, Diabetologia, 22, 46, 10.1007/BF00253869
Barrett-Connor, 1982, Am J Epidemiol, 115, 657, 10.1093/oxfordjournals.aje.a113348
Howard, 1984, Arteriosclerosis, 4, 462, 10.1161/01.ATV.4.5.462
Laakso, 1985, Atherosclerosis, 56, 271, 10.1016/0021-9150(85)90003-6
Abrams, 1982, Diabetes, 31, 903, 10.2337/diabetes.31.10.903
Dunn, 1984, Metabolism, 33, 117, 10.1016/0026-0495(84)90122-7
Taskinen, 1986, Diabetes, 35, 1268, 10.2337/diabetes.35.11.1268
Howard, 1985, Am J Med, 79, 78, 10.1016/S0002-9343(85)80012-7
Hollenbeck, 1985, J Clin Endocrinol Metab, 62, 605, 10.1210/jcem-62-3-605
Kissebah, 1983, J Clin Invest, 71, 655, 10.1172/JCI110812
Yoshino, 1986, Diabetes Res Clin Pract, 2, 179, 10.1016/S0168-8227(86)80020-1
Brown, 1983, J Clin Invest, 72, 743, 10.1172/JCI111044
Myers, 1976, J Lab Clin Med, 88, 491
1984, JAMA, 251, 365, 10.1001/jama.1984.03340270043026
Ingelfinger, 1976, Diabetes, 25, 561, 10.2337/diabetes.25.7.561
Diabetes Drafting Group, 1985, Diabetologia, 28, 615, 10.1007/BF00290267
Pan, 1986, Diabetes Care, 9, 395, 10.2337/diacare.9.4.395
Marks, 1982, Res Clin Forums, 4, 95
Gurian, 1959, Am J Med Sci, 237, 12, 10.1097/00000441-195901000-00003
The Lovastatin Study Group II, 1986, JAMA, 256, 2829, 10.1001/jama.1986.03380200067023
Tobert, 1987, Circulation, 76, 534, 10.1161/01.CIR.76.3.534
